By
Rachel Silverman and Amanda Glassman
Published: June 20, 2019, 11:19 a.m.·
Tags:
Global health,
Access
Healthy competition from generic drugs is often held up as a “cure” for high drug prices — a shared concern across rich and developing countries alike. For many low- and middle-income countries, however, a new report from the Center for Global Development that we co-authored shows that global markets for generic medicines are failing, leaving the poorest patients without safe and affordable essential medicines.
Read More →